Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

308 15 Bone Marrow Transplantation for Immune Therapy
5 Basara N, Blau IW,Willenbacher W,
Kiehl MG, Fauser AA. New strategies
in the treatment of graft-versus-host
disease. Bone Marrow Transplant 2000;
25 (suppl 2): S12±S15.
6 Gaziev D, Galimberti M, Lucarelli G,
Polchi P. Chronic graft-versus-host
disease: is there an alternative to the
conventional treatment? [Review]. Bone
Marrow Transplant 2000; 25: 689±696.
7 Barnes DWH, et al. Treatment of murine
leukemia with X-rays and homologous
bone marro. Preliminary communications.
Br Med J 1956; 2: 626±627.
8 Weiden PL, Flournoy N, Thomas ED,
et al. Antileukemic effect of graft versus
host disease in human recipients of allogeneic
marrow grafts. N Engl J Med
1979; 300: 1068±1073.
9 Horowitz MM, Gale RP, Sondel PM,
et al. Graft-versus-leukemia reactions
after bone marrow transplantation.
Blood 1990; 75: 555±562.
10 Kolb HJ, Mittermuller J, Clemm CH,
et al. Donor leukocyte transfusions for
treatment of recurrent chronic myelogenous
leukemia in marrow transplant
patients. Blood 1990; 76: 2462±2465.
11 Kolb HJ, Schattenberg A, Goldman
JM, et al. Graft-versus-leukemia
effect of donor lymphocytes transfusions
in marrow grafted patients. European
Group for Blood and Marrow
Transplantation Chronic Leukemia
Working Party. Blood 1995; 86: 2041±
2050.
12 Mackinnon S, Papadopoulos EP, Carabasi
MH, et al. Adoptive immunotherapy
evaluating escalating doses of donor
leukocytes for relapse of chronic
myeloid leukemia following bone marrow
transplantation: separation of graftversus-leukemia
responses from graftversus-host
disease. Blood 1995; 86:
1261±1268.
13 Collins RH, Shpilberg OJ, Drobyski
WR, et al. Donor leukocyte infusions
in 140 patients with relapsed malignancy
after allogeneic bone marrow
transplantation. J Clin Oncol 1997; 15:
433±444.
14 Porter DL, Connors JM,Van Deerlin
VM, et al. Graft-versus-tumor induction
with donor leukocyte infusions
as primary therapy for patients with
malignancies. J Clin Oncol 1999; 17:
1234.
15 Collins RH Jr, Goldstein S, Giralt S,
et al. Donor leukocyte infusions in
acute lymphocytic leukemia. Bone Marrow
Transplant 2000; 26: 511±516.
16 Schmid C, Lange C, Salat C, et al.
Treatment of recurrent acute leukemia
after marrow transplantation with donor
cells and GM-CSF. Blood 1999; 94
(10 suppl 1), 668a (abstr 2965).
17 Porter DL, Collins RH Jr, Shpilberg
O, et al. Long-term follow-up of
patients who achieved complete remission
after donor leukocyte infusions.
Biol Blood Marrow Transplant 1999; 5:
253±261.
18 Lokhorst HM, Schattenberg A, Cornelissen
JJ, et al. Donor leukocyte infusions
are effective in relapsed multiple
myeloma after allogeneic bone marrow
transplantation. Blood 1997; 90: 4206±
4212.
19 Mandigers CM, Meijerink JP, Raemaekers
JM, Schattenberg AV, Mensink
EJ. Graft-versus-lymphoma effect
of donor leucocyte infusion shown by
real-time quantitative PCR analysis of
t(14;18). Lancet 1998; 352: 1522±1523.
20 Dazzi F, Szydlo RM, Craddock C,
et al. Comparison of single-dose and escalating-dose
regimens of donor lymphocyte
infusion for relapse after allografting
for chronic myeloid leukemia.
Blood 2000; 95: 67±71.
21 Giralt S, Hester J, Huh Y, et al. CD8depleted
donor lymphocyte infusion as
treatment for relapsed chronic myelogenous
leukemia after allogeneic BMT.
Blood 1995; 86: 4337±4343.
22 Falkenburg JHF,Wafelman AR, Joosten
P, et al. Complete remission of accelerated
phase CML by treatment with
leukemia-reactive cytotoxic T lymphocytes.
Blood, 1999; 94: 1201±1208.
23 Bordignon C, Carlostella C, Colombo
MP, et al. Cell therapy: achievements
and perspectives. Haematologica
1999; 84: 1100±1149.
24 Bordignon C, Bonini C. A clinical
protocol for gene transfer into peripheral
blood lymphocytes for in vivo immunomodulation
of donor anti-tumor